Lack of pragmatic attitude of self-labelled pragmatic trials on manual therapy: a methodological review
Author
Other authors
Publication date
2024-11Abstract
Background Pragmatic randomized controlled trials are getting more interest to improve trials’ external validity. This
study aimed to assess how pragmatic the design of the self-labelled pragmatic randomised controlled trials in the
manual therapy field is.
Methods We searched MEDLINE and the Cochrane Central Register of Controlled Trials for self-labelled pragmatic
randomised controlled trials in the manual therapy field until January 2024 were included. Two independent
reviewers collected and extracted data related to the intention of the trial, the rationale for the intervention, and
specific features of the trial and performed an assessment using the PRECIS-2 tool.
Results Of 39 self-labelled pragmatic trials, the mean PRECIS-2 score was 3.5 (SD: 0.6). Choice of outcome measures,
how the interventions were performed, the follow-up of the participants and how all the available data were included
in the statistical analysis were the domains rated as most ‘pragmatic’. Participants’ eligibility, recruitment, and setting
obtained lower scores. Less than 25% of the trials claimed that the aim was to investigate an intervention under
real-world conditions and to make clinical decisions about its effectiveness. In the 21% of the sample the authors
described neither the proof-of-concept of the intervention nor the state of previous studies addressing related
research questions.
Conclusions Self-labelled pragmatic randomised controlled trials showed a moderately pragmatic attitude. Beyond
the label ‘pragmatic’, the description of the intention of the trial and the context of every PRECIS-2 domain is crucial to
understanding the real pragmatism of a trial.
Document Type
Article
Document version
Published version
Language
English
Keywords
Assaigs clínics
Aparell locomotor
Manipulació (Terapèutica)
Teràpia manual
Generalitzabilitat
PRECIS-2
Pages
12 p.
Publisher
BioMed Central
Is part of
BMC Medical Research Methodology, 2024, 24: 273
This item appears in the following Collection(s)
Rights
© L'autor/a
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/